Results 51 to 60 of about 2,928 (195)

α1‐Adrenergic Receptors Function Within Hetero‐Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C‐X‐C motif) Receptor 4 in Vascular Smooth Muscle Cells

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundRecently, we provided evidence that α1‐adrenergic receptors (ARs) in vascular smooth muscle are regulated by chemokine (C‐X‐C motif) receptor (CXCR) 4 and atypical chemokine receptor 3 (ACKR3). While we showed that CXCR4 controls α1‐ARs through
Lauren J. Albee   +7 more
doaj   +1 more source

ACKR3–arrestin2/3 complexes reveal molecular consequences of GRK-dependent barcoding

open access: yesbioRxiv, 2023
Atypical chemokine receptor 3 (ACKR3, also known as CXCR7) is a scavenger receptor that regulates extracellular levels of the chemokine CXCL12 to maintain responsiveness of its partner, the G protein-coupled receptor (GPCR), CXCR4.
Qiuyan Chen   +8 more
semanticscholar   +1 more source

The atypical chemokine receptor 3 interacts with Connexin 43 inhibiting astrocytic gap junctional intercellular communication

open access: yesNature Communications, 2020
The atypical chemokine receptor 3 (ACKR3) is known to regulate cell migration, but the underlying mechanisms are unclear. Here, the authors show, from an interactome analysis, ACKR3 association with the gap junction protein Connexin 43 in vivo and ACKR3 ...
Amos Fumagalli   +15 more
doaj   +1 more source

Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes

open access: yesbioRxiv, 2023
The canonical chemokine receptor CXCR4 and atypical receptor ACKR3 both respond to CXCL12 but induce different effector responses to regulate cell migration.
Christopher T. Schafer   +4 more
semanticscholar   +1 more source

CXCR4 and ACKR3 binding agents for imaging applications in cancer [PDF]

open access: yes, 2019
The chemokine receptors CXCR4 and ACKR3 have been shown to be over-expressed in multiple types of cancer and are usually associated with aggressive phenotypes and poor prognosis. Successfully targeting and imaging the expression levels of these receptors
Renard, Isaline
core   +6 more sources

Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function. [PDF]

open access: yesPLoS ONE, 2017
Recent evidence suggests that chemokine CXCL12, the cognate agonist of chemokine receptors CXCR4 and ACKR3, reduces thrombin-mediated impairment of endothelial barrier function.
You-Hong Cheng   +4 more
doaj   +1 more source

Glia Cells Control Olfactory Neurogenesis by Fine-Tuning CXCL12

open access: yesCells, 2023
Olfaction depends on lifelong production of sensory neurons from CXCR4 expressing neurogenic stem cells. Signaling by CXCR4 depends on the concentration of CXCL12, CXCR4’s principal ligand.
André Dietz   +4 more
doaj   +1 more source

Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets

open access: yesCells, 2022
Chemokines are molecules that pertain to a family of small cytokines and can generate cell chemotaxis through the interaction with their receptors.
Messias Oliveira Pacheco   +3 more
doaj   +1 more source

Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3

open access: yesMolecular Pharmacology, 2023
Atypical chemokine receptor 3 (ACKR3), formerly referred to as CXCR7, is considered to be an interesting drug target. In this study, we report on the synthesis, pharmacological characterization and radiolabeling of VUF15485, a new ACKR3 small-molecule ...
Aurelien M. Zarca   +24 more
semanticscholar   +1 more source

Research progress on the atypical chemokine receptor ACKR3 in cancer

open access: yesXin yixue
Atypical chemokine receptor 3 (ACKR3), also known as CXC chemokine receptor 7 (CXCR7), has attracted increasing attention for its regulatory roles in the tumor microenvironment.
Pan SUN, Lei XU, Juan YANG
doaj   +1 more source

Home - About - Disclaimer - Privacy